|
Q4 2021
Filed on Feb 04, 2022
|
38,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 04, 2022
|
40,500
|
$21.72 - $29.98
$880K - $1.21M
|
|
|
Q4 2021
Filed on Feb 04, 2022
|
14,400
|
$33.93 - $41.2
$489K - $593K
|
|
|
Q4 2021
Filed on Feb 04, 2022
|
27,000
|
$68.16 - $81.31
$1.84M - $2.2M
|
|
|
Q4 2021
Filed on Feb 04, 2022
|
27,000
|
$15.76 - $33.25
$426K - $898K
|
|
|
Q4 2021
Filed on Feb 04, 2022
|
500,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 04, 2022
|
1,900,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 04, 2022
|
21,825
|
$52.55 - $58.91
$1.15M - $1.29M
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
61,750
|
$17.11 - $20.8
$1.06M - $1.28M
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
19,000
|
$22.7 - $33.52
$431K - $637K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
23,500
|
$10.98 - $13.29
$258K - $312K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
153,000
|
$6.03 - $7.96
$923K - $1.22M
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
38,000
|
$19.26 - $26.02
$732K - $989K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
110,500
|
$9.02 - $11.88
$997K - $1.31M
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
7,500
|
$40.11 - $61.89
$301K - $464K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
237,500
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
95,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
6,000
|
$43.06 - $48.76
$258K - $293K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
23,750
|
$21.95 - $32.86
$521K - $780K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
85,500
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
66,500
|
$22.64 - $33.45
$1.51M - $2.22M
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
46,419
|
$20.35 - $26.63
$945K - $1.24M
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
14,250
|
$47.73 - $54.86
$680K - $782K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
17,000
|
$24.31 - $33.6
$413K - $571K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
2,000
|
$59.25 - $66.95
$119K - $134K
|
|
Ecp Environmental Gw Opt Cor
|
Q3 2021
Filed on Nov 12, 2021
|
1,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
1,000
|
$18.54 - $26.62
$18.5K - $26.6K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
33,674
|
$1.96 - $2.42
$66K - $81.5K
|
|
Decarbonization Plus Acqu Ii
|
Q3 2021
Filed on Nov 12, 2021
|
900
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
14,250
|
$24.93 - $35.75
$355K - $509K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
38,000
|
$13.8 - $22.94
$524K - $872K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
17,500
|
$12.98 - $16.46
$227K - $288K
|
|
Paratek Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 12, 2021
|
750,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
1,350,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
27,200
|
N/A
|
|
Ligand Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 12, 2021
|
900,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
38,000
|
$31.83 - $39.18
$1.21M - $1.49M
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
3,000
|
$144.3 - $190.65
$433K - $572K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
7,519
|
$8.55 - $16.51
$64.3K - $124K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
21,021
|
$30.02 - $39.87
$631K - $838K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
1,000,000
|
N/A
|
|
Spartan Acquisition Corp Iii
|
Q3 2021
Filed on Nov 12, 2021
|
1,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
3,000
|
$21.6 - $25.2
$64.8K - $75.6K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
2,700
|
$46.1 - $63.75
$124K - $172K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
17,615
|
$4.14 - $22.9
$72.9K - $403K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
14,250
|
$25.8 - $37.61
$368K - $536K
|
|
|
Q2 2021
Filed on Aug 12, 2021
|
9,000
|
$76.8 - $95.59
$691K - $860K
|
|
Marinus Pharmaceuticals Inc
|
Q2 2021
Filed on Aug 12, 2021
|
70,623
|
N/A
|
|
Invesco Exch Traded Fd Tr Ii
|
Q2 2021
Filed on Aug 12, 2021
|
67,500
|
N/A
|
|
|
Q2 2021
Filed on Aug 12, 2021
|
13,500
|
$42.73 - $53.79
$577K - $726K
|
|